Colour enhancement

From PsychonautWiki
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
Tree.jpgJapanese Garden by Anonymous
25B-NBOMe
GABAergic hallucinogens
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
Efavirenz
4-AcO-DET
4-HO-EPT
MDAI
THJ-018
Experience:300µg LSD - Togetherness and the Silent Dusk
Chur City in Switzerland.jpgChur, Switzerland by Naps284
5-Hydroxytryptophan
LSA
LSD
EPT
Experience:4x 200ug tabs - You do not need to understand
5-MeO-MiPT
2C-T-21
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
Experience:337mg DMT fumarate - A Day With DMT
Phenethylamine (compound)
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
2C-E
25B-NBOH
Experience:~150mg MDA(oral) - a case of mistaken identity
Pregabalin
4-AcO-MiPT
Experience:250mg DXM - DXM Itch and Trip Report
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
3-MeO-PCE
Experience:1mg 25c-NBOMe - Experiment in my room
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
4-FA
2C-P
JWH-018
MiPT
DPT
Phenylpiracetam
4-HO-DiPT
PRO-LAD
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
4-AcO-MET
Experience:3-MeO-PCP - Extreme psychosis
25C-NBOMe
ETH-LAD
Experience:25mg Deschloroketamine - My first time orally dosing DCK
Escaline
DiPT
ΑMT
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
Experience:BK-2C-B - Various experiences
Experience:120mg - Garden of The Gods
5-MeO-DALT
6-APB
MET
Psilocin
25I-NBOH
Pramiracetam
AL-LAD
1P-ETH-LAD
MiPLA
TMA-2
DOC
2C-I
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
MDA
Omberacetam
2C-T-2
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
DOI
3-MMC
Experience:2 tabs DOB - My DOB Nightmare
Paradise island by Xanny.jpgParadise island by Subsentience
TMA-6
25N-NBOMe
JWH-073
Allylescaline
Amanita muscaria
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
DMT
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
MDMA
2C-D
1P-LSD
LSM-775
Experience:4-AcO-DMT + 200mg Pill
Aniracetam
Experience:3g mimosa / 3g syrian rue - Connecting with my body
Experience:1050 µg 1cP-LSD - The matrix
6-APDB
Experience:1000 Morning Glory seeds - Rediscovering the Self
25I-NBOMe
MPT
25D-NBOMe
Experience:4.5g - The Grand Introduction to Beauty and Fear
LSZ
Proscaline
1B-LSD
2C-B-FLY
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
4-AcO-DiPT
Ibogaine
Experience:25mg 3-MeO-PCP - Enhanced film experience
Oxiracetam
4-HO-MPT
ALD-52
Ayahuasca
Selective serotonin reuptake inhibitor
Bromo-DragonFLY
Memantine
THJ-2201
Mescaline
2C-T-7
DOM
2C-C
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
PARGY-LAD
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
Βk-2C-B
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
Experience:300µg AL-LAD - Don't worry, because you're everyone!
Enhancement of colour rose.jpgRose by Chelsea Morgan
4-HO-DPT
Experience:4-HO-MiPT / A care free psychedelic getaway
2C-B
Methallylescaline
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
4-HO-MET
Experience:800 seeds LSA - My First Trip Ever
5-MeO-DiBF
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
4-HO-DET
DET
4-AcO-DMT
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
2C-H
Bufotenin
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
Piracetam
DOB
Coluracetam
Psilocybin mushrooms
MDEA
5-MeO-DiPT
25C-NBOH
5F-PB-22
3C-E
Chameleon.jpgChameleon by Anonymous.
Experience:40mg - Brothermind and the Forest's Hand
4-HO-MiPT

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.